Intel Q4 Guidance Deemed Weak and 4 Stock Analyses to Track

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Unitedhealth Group, Inc. (NYSE:UNH): According to Bernstein, UnitedHealth reported solid Q3 results, and the firm believes that P/E ratio of the stock will expand in the near future. The firm keeps its Outperform rating on the stock.

Intel Corporation (NASDAQ:INTC) target has been reduced by Bernstein since the firm thinks that the company’s Q4 revenue guidance appeared weak. The firm does not fully believe that Intel’s weakness is cyclical instead of structural, and it keeps its Underperform rating on the stock.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

International Business Machines Corp. (NYSE:IBM) reported lower Q2 revenue than previously expected, causing Wells Fargo to believe that the stock’s multiple probably will not expand. The firm keeps a Market Perform rating on the stock.

Fortinet Inc. (NASDAQ:FTNT) reported Q3 results in-line with its guidance and keeps its 2012 outlook, influencing Stifel Nicolaus to think that the subsequent 17 percent drop in the stock duringt after-hours trading was overdone. The firm believes that the company’s growth outlook continues to be mainly intact, and it keeps its Buy rating on the stock.

Cree Inc. (NASDAQ:CREE): According to Susquehanna, Cree reported in-line Q1 results, but the company stated that gross margins saw improvement and were guided to improve again the following quarter. The firm thinks that the results indicate good traction going forward, and it reiterates its Positive rating and a $36 price target on the stock.

Don’t Miss: Here’s Why Cisco and Citrix Are Finally Tying the Knot.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business